0001062993-23-003530.txt : 20230214
0001062993-23-003530.hdr.sgml : 20230214
20230214180454
ACCESSION NUMBER: 0001062993-23-003530
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221231
FILED AS OF DATE: 20230214
DATE AS OF CHANGE: 20230214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Edward Aloysius Jr.
CENTRAL INDEX KEY: 0001929093
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41403
FILM NUMBER: 23632423
MAIL ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc.
CENTRAL INDEX KEY: 0001907685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 874706968
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (617)871-2101
MAIL ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
5
1
form5.xml
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
X0306
5
2022-12-31
0
1
0001907685
Comera Life Sciences Holdings, Inc.
CMRA
0001929093
Sullivan Edward Aloysius Jr.
C/O COMERA LIFE SCIENCES HOLDINGS, INC.
12 GILL STREET, SUITE 4650
WOBURN
MA
01801
1
0
0
0
Stock Option (Right to Buy)
0.59
2022-05-19
4
A
0
44981
A
2031-09-16
Common Stock
44981
44981
D
The shares underlying the option vest in 48 equal monthly installments beginning on September 16, 2021.
This option was issued pursuant to the terms of a business combination agreement involving the issuer and Comera Life Sciences, Inc. in exchange for a comparable option previously issued by such company.
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
2023-02-14